Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2006229
Max Phase: Preclinical
Molecular Formula: C9H7N3OS2
Molecular Weight: 237.31
Molecule Type: Small molecule
Associated Items:
ID: ALA2006229
Max Phase: Preclinical
Molecular Formula: C9H7N3OS2
Molecular Weight: 237.31
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=c1[nH]nc(Sc2ccccc2)c(=S)[nH]1
Standard InChI: InChI=1S/C9H7N3OS2/c13-9-10-7(14)8(11-12-9)15-6-4-2-1-3-5-6/h1-5H,(H2,10,12,13,14)
Standard InChI Key: RYPQVHLIYDCZEC-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 237.31 | Molecular Weight (Monoisotopic): 237.0031 | AlogP: 1.98 | #Rotatable Bonds: 2 |
Polar Surface Area: 61.54 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.14 | CX Basic pKa: | CX LogP: 2.21 | CX LogD: 1.77 |
Aromatic Rings: 2 | Heavy Atoms: 15 | QED Weighted: 0.78 | Np Likeness Score: -1.56 |
1. PubChem BioAssay data set, |
Source(1):